Latest Close
$0.34
News
SCNX
Scienture Holdings, Inc. News
This news view pulls recent coverage and headlines tied to SCNX.
1y Change
-$0.51 (-60.16%)
Market Cap
$13,757,595.00
Sector
Healthcare
Industry
Pharmaceutical Retailers
Recommendation
none
Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead
GlobeNewswire • Apr 6, 2026
Read articleScienture Holdings: Q4 Earnings Snapshot
Associated Press • Mar 30, 2026
Read articleSCIENTURE Reports Year End 2025 Financial Results and Provides Business Update
GlobeNewswire • Mar 30, 2026
Read articleBC-Most Active Stocks
Associated Press Finance • Mar 11, 2026
Read articleSCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions
GlobeNewswire • Mar 11, 2026
Read articleSCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium
GlobeNewswire • Feb 3, 2026
Read article